Investment Thesis
Despite 6.6% revenue growth and profitable operations (11.4% net margin), Genpact exhibits fundamental weakness through negative operating cash flow (-$23.5M) and negative free cash flow (-$47.5M), indicating poor cash conversion and potential working capital or restructuring challenges. Combined with depressed returns (ROE 6.0%, ROA 2.6%) and flat net income growth despite revenue expansion, the company demonstrates inadequate capital efficiency and concerning operational execution.
Strengths
- Revenue growth of 6.6% YoY demonstrates market demand and client retention in consulting services
- Healthy liquidity position with current ratio of 1.69x and $578.1M cash provides financial flexibility
- Moderate leverage with debt-to-equity of 0.62x maintains reasonable balance sheet stability
Risks
- Negative operating cash flow of -$23.5M and free cash flow of -$47.5M despite profitability signals cash conversion crisis or major working capital deterioration
- Flat net income growth (0.0% YoY) while revenue grew 6.6% indicates margin compression or cost structure pressures
- Very low returns on equity (6.0%) and assets (2.6%) suggest inefficient capital deployment and value destruction
Key Metrics to Watch
- Operating and free cash flow trajectory—must turn positive to validate profitability claims
- Net margin trend relative to revenue growth—monitor for stabilization of profitability
- Return on equity improvement and working capital management efficiency in subsequent quarters
Financial Metrics
Revenue
1.3B
Net Income
148.0M
EPS (Diluted)
$0.86
Free Cash Flow
-47.5M
Total Assets
5.6B
Cash
578.1M
Profitability Ratios
Gross Margin
36.4%
Operating Margin
15.3%
Net Margin
11.4%
ROE
6.0%
ROA
2.6%
FCF Margin
-3.7%
Balance Sheet & Liquidity
Current Ratio
1.69x
Quick Ratio
1.69x
Debt/Equity
0.62x
Debt/Assets
55.9%
Interest Coverage
N/A
Long-term Debt
1.5B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T10:45:16.535770 |
Data as of: 2026-03-31 |
Powered by Claude AI